Quick Answer
FILANA THERAPEUTICS, INC. reported Stockholders Equity of $74.40 million for fiscal year 2025.
FILANA THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $74.40M | -48.9% |
| 2024 | $145.70M | +6.0% |
| 2023 | $137.47M | -39.6% |
| 2022 | $227.54M | -10.4% |
| 2021 | $253.91M | +175.4% |
| 2020 | $92.20M | +317.2% |
| 2019 | $22.10M | +12.6% |
| 2018 | $19.63M | +102.4% |
| 2017 | $9.70M | -48.0% |
| 2016 | $18.64M | -36.5% |
| 2015 | $29.37M | -26.7% |
| 2014 | $40.06M | -17.1% |
| 2013 | $48.30M | +267.7% |
| 2012 | $13.14M | -70.4% |
| 2011 | $44.39M | +34.8% |
| 2010 | $32.93M | -69.6% |
| 2009 | $108.25M | +3.8% |
| 2008 | $104.29M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $81.57M | -51.1% | -7.3% |
| June 30, 2025 | $87.97M | -53.4% | -31.1% |
| March 31, 2025 | $127.62M | +62.4% | -12.4% |
| December 31, 2024 | $145.70M | +6.0% | -12.6% |
| September 30, 2024 | $166.64M | +7.4% | -11.8% |
| June 30, 2024 | $188.97M | +5.4% | +140.4% |
| March 31, 2024 | $78.60M | -61.5% | -42.8% |
| December 31, 2023 | $137.47M | -39.6% | -11.4% |
- FILANA THERAPEUTICS, INC. showed a decrease of -48.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, FILANA THERAPEUTICS, INC.’s stockholders equity has declined by 28.7% (from $104.29 million to $74.40 million).
- The most recent figure is from FILANA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: